Upcoming Participation in Major Healthcare Conferences
Alpha Tau Medical Ltd., a leading developer of innovative cancer therapies, is gearing up for an exciting presence at significant healthcare conferences. The involvement of the Chief Financial Officer, Raphi Levy, at these events marks a pivotal opportunity for the company to showcase its groundbreaking alpha-radiation cancer therapy, known as Alpha DaRT.
Presentations at Healthcare Conferences
Alpha Tau will participate in the Citi 2024 Global Healthcare Conference as well as the Piper Sandler 36th Annual Healthcare Conference. These conferences are exclusive forums where leading firms in the healthcare sector connect with investors and stakeholders. Raphi Levy's participation illustrates Alpha Tau's commitment to transparency and investor engagement in the rapidly evolving oncology space.
Citi 2024 Global Healthcare Conference Details
The Citi 2024 Global Healthcare Conference is set to take place in Miami, Florida, featuring a format that includes one-on-one meetings, enabling attendees to engage directly with company representatives. The event will occur on a specific date and will run from morning to late afternoon, allowing ample opportunity for in-depth discussions regarding investments and innovations in the healthcare sector.
Piper Sandler 36th Annual Healthcare Conference Overview
Following the Citi conference, Alpha Tau will also appear at the Piper Sandler 36th Annual Healthcare Conference. This event will feature fireside chats and additional one-on-one meetings. The format promotes engaging discussions around Alpha Tau's innovative therapies and their potential impacts on cancer treatment.
About Alpha Tau Medical Ltd.
Established in 2016, Alpha Tau Medical Ltd. is an Israeli company specializing in oncology therapeutics. The company is renowned for its focus on creating treatments that harness the power of alpha-radiation, particularly with its flagship therapy, Alpha DaRT. Developed initially by esteemed professors from Tel Aviv University, the therapy represents a cutting-edge approach to combat solid tumors.
Understanding Alpha DaRT Technology
Alpha DaRT, which stands for Diffusing Alpha-emitters Radiation Therapy, is a sophisticated treatment designed to deliver targeted alpha-irradiation specifically to solid tumors. The system utilizes radium-224 sources that emit high-energy alpha particles, designed to focus primarily on the tumor itself. This method ensures minimal damage to surrounding healthy tissues, representing a significant advancement in cancer treatment technology.
Looking Ahead: Investor Relations and Opportunities
As Alpha Tau prepares for these two important healthcare conferences, it encourages interested stakeholders and investors to reach out to set up meetings. This proactive approach highlights the company's strategy to maintain open lines of communication with those interested in its journey and progress. By engaging with investors, Alpha Tau reinforces its commitment to transparency and collaboration within the competitive healthcare landscape.
Frequently Asked Questions
What is Alpha DaRT and how does it work?
Alpha DaRT utilizes alpha-emitters to deliver targeted radiation to tumors, promoting tumor destruction while sparing healthy tissue around it.
Who is attending the upcoming conferences on behalf of Alpha Tau?
The Chief Financial Officer, Raphi Levy, will represent Alpha Tau at both the Citi and Piper Sandler conferences.
When will these conferences take place?
The Citi conference is on December 3 and the Piper Sandler conference is set for December 5.
Where are the conferences being held?
The Citi conference will be in Miami, Florida, while the Piper Sandler conference will be located in New York City.
How can investors connect with Alpha Tau during these events?
Investors are encouraged to reach out to their respective Citi and Piper Sandler representatives to schedule one-on-one meetings with Alpha Tau's leadership.
